Table 4.
Association of various demographic and treatment factors with persistent fatigue
| Demographic characteristics | Patients with fatigue (n=74) | Patients without fatigue (n=11) | Total | P |
|---|---|---|---|---|
| Age (Mean±SD) | 56.15±13.64 | 46.27±14.89 | 54.87±14.11 | 0.029§ |
| Female | 38 | 4 | 42 | 0.52* |
| Male | 36 | 7 | 43 | |
| BMI (Mean±SD) | 26.11±5.92 | 24.82±4.79 | 25.95±5.77 | 0.49§ |
| Patients with comorbidities | 45 | 3 | 48 | 0.051* |
| Patients without comorbidities | 29 | 8 | 37 | |
| Steroid therapy received | 52 | 4 | 56 | 0.04* |
| Antiviral therapy received | 5 | 0 | 5 | 1* |
| Oxygen therapy received | 51 | 3 | 54 | 0.015* |
| NIV support received | 3 | 0 | 3 | 1* |
| Median duration of hospital stay | 13 | 0 | 12 | 0.01¶ |
*Fisher's exact test, §Independent t-test, ¶Mann Whitney test. BMI - Body mass index, SD - Standard deviation